
Glimguard M 1mg/500mg Tablet SR
Marketer
Kevlar Healthcare
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimguard M 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation may lead to elevated blood sugar, increasing the risk of kidney complications, vision impairment, neuropathy, and limb loss. This medication is part of a comprehensive diabetes management plan that includes diet, exercise, and weight management as recommended by your doctor. Lifestyle modifications are integral to diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, characterized by sweating, dizziness, headache, and tremors. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential for prevention. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before starting treatment. Consult your doctor before use during pregnancy or breastfeeding. Regular blood glucose monitoring and periodic blood tests (complete blood count and liver function tests) are recommended.
Primary Ingredients of Glimguard M 1mg/500mg Tablet SR
No text was provided to rewrite.
Uses of Glimguard M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimguard M 1mg/500mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimguard M 1mg/500mg Extended-Release Tablet with food.
Common Side effects of Glimguard M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimguard M 1mg/500mg Tablet SR:
Consume this medication precisely as prescribed by your physician, adhering to the advised dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Glimguard M 1mg/500mg Extended-Release Tablet with a meal.
How Glimguard M 1mg/500mg Tablet SR works:
Glimguard M 1mg/500mg sustained-release tablets combine glimepiride and metformin, two antidiabetic agents. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent alcohol consumption and Glimguard M 1mg/500mg SR tablets is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Glimguard M 1mg/500mg SR tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks before prescribing. Always seek medical advice.
Breast feedingUNSAFE
Extended-release Glimguard M tablets (1mg/500mg) are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.
DrivingCAUTION
Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.
KidneyCAUTION
Patients with kidney impairment should use Glimguard M 1mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is recommended. Glimguard M 1mg/500mg Tablet SR is contraindicated in individuals with severe kidney disease. Routine monitoring of renal function is advised during treatment.
LiverCAUTION
Individuals with liver impairment should exercise caution when using Glimguard M 1mg/500mg Tablet SR. Dosage modification of Glimguard M 1mg/500mg Tablet SR may be necessary. Physician consultation is advised. For those with mild to moderate liver disease, Glimguard M 1mg/500mg Tablet SR is typically initiated at a low dosage; however, it's contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimguard M 1mg/500mg Tablet SR :
Should you forget a dose of Glimguard M 1mg/500mg Extended-Release Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimguard M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
